🔴 Exclusive webinar: The Secrets of ProPicks AI Success Revealed + November’s List FREEWatch Now

Zoetis Inc (ZTS)

NYSE
Currency in USD
173.96
-2.19(-1.24%)
Closed
After Hours
175.99+2.03(+1.17%)
ZTS Scorecard
Full Analysis
Management has been aggressively buying back shares
Fair Value
Day's Range
173.75176.51
52 wk Range
144.80201.92
Prev. Close
176.15
Open
175.39
Day's Range
173.75-176.51
52 wk Range
144.8-201.92
Volume
2,179,244
Average Vol. (3m)
1,964,803
1-Year Change
4.03%
Book Value / Share
Unlock
Fair Value
Unlock
Fair Value Upside
Unlock
ZTS Scorecardpro icon
Company’s Health
pro lockUnlock
Fair Value
pro lockUnlock Price
Fair Pricepro lock
Upsidepro lock
Price Target
214.78
Upside
+23.47%
Members' Sentiments
Bearish
Bullish
ProTips
Has raised its dividend for 12 consecutive years
Show more

Zoetis Inc Company Profile

Zoetis Inc. engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses. It also offers parasiticides, vaccines, dermatology, other pharmaceutical, anti-infectives, animal health diagnostics, and medicated feed additives. In addition, the company provides animal health diagnostics, including point-of-care diagnostic products, instruments and reagents, rapid immunoassay tests, reference laboratory kits and services, and blood glucose monitors; and other non-pharmaceutical products, which include nutritionals, as well as products and services in biodevices, genetic tests, and precision animal health. It markets its products to veterinarians, livestock producers, and pet owners. The company has collaboration Blacksmith Medicines, Inc. to discover and develop novel antibiotics for animal health. Zoetis Inc. was founded in 1952 and is headquartered in Parsippany, New Jersey.

Employees
14100

InvestingPro Research for Zoetis Inc


Future Prospects
Delve into Zoetis's strategies for tapping untapped markets in animal anti-depressants and pain management, while navigating challenges like foreign exchange impacts
Product Innovation
Explore Zoetis's key growth drivers, including Librela for canine osteoarthritis and Apoquel for dermatology, alongside a promising pipeline in oncology and cardiology
Financial Resilience
Analysts project continued growth, with Q3 2024 organic revenue expected to rise 9.2%. Price targets range from $225 to $242, reflecting positive outlook
Market Leadership
Zoetis maintains dominance in animal health, with a robust portfolio spanning companion animal and livestock sectors, despite increasing competition
Read full SWOT analysis

Compare ZTS to Peers and Sector

Metrics to compare
ZTS
Peers
Sector
Relationship
P/E Ratio
32.3x−6.4x−0.6x
PEG Ratio
3.900.060.00
Price / Book
15.0x1.2x2.6x
Price / LTM Sales
8.6x1.9x3.2x
Upside (Analyst Target)
21.5%80.0%43.6%
Fair Value Upside
Unlock18.6%5.8%Unlock

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 5.33
Dividend Yield
0.98%
Industry Median 1.75%
Annualized Payout
1.7280
Paid quarterly
5-Years Growth
+22.01%
Growth Streak

People Also Watch

282.89
CB
+0.78%
119.87
TJX
+1.53%
297.77
CDNS
-1.04%
224.79
NXPI
-0.99%
239.60
DHR
-1.50%

FAQ

What Is the Zoetis Inc (ZTS) Stock Price Today?

The Zoetis Inc stock price today is 173.96

What Stock Exchange Does Zoetis Inc Trade On?

Zoetis Inc is listed and trades on the NYSE stock exchange.

What Is the Stock Symbol for Zoetis Inc?

The stock symbol for Zoetis Inc is "ZTS."

Does Zoetis Inc Pay Dividends? What’s The Current Dividend Yield?

The dividend yield is 0.98%.

What Is the Zoetis Inc Market Cap?

As of today, Zoetis Inc market cap is 78.62B.

What is Zoetis Inc Earnings Per Share?

The Zoetis Inc EPS is 5.33.

What Is the Next Zoetis Inc Earnings Date?

Zoetis Inc will release its next earnings report on Feb 18, 2025.

From a Technical Analysis Perspective, Is ZTS a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.